284 related articles for article (PubMed ID: 3305134)
1. Evidence for platelet-activating factor as a mediator of endotoxin-induced gastrointestinal damage in the rat. Effects of three platelet-activating factor antagonists.
Wallace JL; Steel G; Whittle BJ; Lagente V; Vargaftig B
Gastroenterology; 1987 Oct; 93(4):765-73. PubMed ID: 3305134
[TBL] [Abstract][Full Text] [Related]
2. Effects of the specific platelet-activating factor antagonists, BN 52021 and BN 52063, on various experimental gastrointestinal ulcerations.
Braquet P; Etienne A; Mencia-Huerta JM; Clostre F
Eur J Pharmacol; 1988 Jun; 150(3):269-76. PubMed ID: 3046952
[TBL] [Abstract][Full Text] [Related]
3. Effects of a platelet-activating factor antagonist, CV-3988, on different shock models in the rat.
Toth PD; Mikulaschek AW
Circ Shock; 1986; 20(3):193-203. PubMed ID: 3802423
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal plasma leakage in endotoxic shock. Inhibition by prostaglandin E2 and by a platelet-activating factor antagonist.
Wallace JL; Steel G; Whittle BJ
Can J Physiol Pharmacol; 1987 Jul; 65(7):1428-32. PubMed ID: 3478114
[TBL] [Abstract][Full Text] [Related]
5. Interference of the PAF-acether antagonist BN 52021 with endotoxin-induced hypotension in the guinea-pig.
Adnot S; Lefort J; Braquet P; Vargaftig BB
Prostaglandins; 1986 Dec; 32(6):791-802. PubMed ID: 3562865
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of rat endotoxin-induced lethality by BN 52021 and BN 52063, compounds with PAF-acether antagonistic effect and protease-inhibitory activity.
Etienne A; Hecquet F; Guilmard C; Soulard C; Braquet P
Int J Tissue React; 1987; 9(1):19-26. PubMed ID: 3596954
[TBL] [Abstract][Full Text] [Related]
7. Is platelet activating factor (PAF) a mediator of endotoxin shock?
Terashita Z; Imura Y; Nishikawa K; Sumida S
Eur J Pharmacol; 1985 Feb; 109(2):257-61. PubMed ID: 3996473
[TBL] [Abstract][Full Text] [Related]
8. Antagonists of PAF-acether do not suppress thrombin-induced aggregation of ADP-deprived and aspirin-treated human platelets.
Adnot S; Joseph D; Vargaftig BB
Agents Actions; 1987 Jun; 21(1-2):195-202. PubMed ID: 3115070
[TBL] [Abstract][Full Text] [Related]
9. Myoelectric intestinal disturbances in Escherichia coli endotoxic shock in rats. Involvement of platelet-activating factor.
Pons L; Droy-Lefaix MT; Braquet P; Buéno L
Lipids; 1991 Dec; 26(12):1359-61. PubMed ID: 1819734
[TBL] [Abstract][Full Text] [Related]
10. In vivo inhibition of plasma protein leakage and Salmonella enteritidis-induced mortality in the rat by a specific paf-acether antagonist: BN 52021.
Etienne A; Hecquet F; Soulard C; Spinnewyn B; Clostre F; Braquet P
Agents Actions; 1986 Jan; 17(3-4):368-70. PubMed ID: 3515870
[TBL] [Abstract][Full Text] [Related]
11. Role for intracellular platelet-activating factor in the circulatory failure in a model of gram-positive shock.
De Kimpe SJ; Thiemermann C; Vane JR
Br J Pharmacol; 1995 Dec; 116(8):3191-8. PubMed ID: 8719795
[TBL] [Abstract][Full Text] [Related]
12. Species difference in the specific receptors of platelet activating factor.
Hwang SB; Lam MH
Biochem Pharmacol; 1986 Dec; 35(24):4511-8. PubMed ID: 3024653
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of the PAF-antagonist BN 52021 on several models of gastro-intestinal mucosal damage in rats.
Etienne A; Thonier F; Braquet P
Int J Tissue React; 1989; 11(2):59-64. PubMed ID: 2693389
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.
Terashita Z; Kawamura M; Takatani M; Tsushima S; Imura Y; Nishikawa K
J Pharmacol Exp Ther; 1992 Feb; 260(2):748-55. PubMed ID: 1738121
[TBL] [Abstract][Full Text] [Related]
15. Involvement of platelet-activating factor (PAF) in endotoxin-induced intestinal motor disturbances in rats.
Pons L; Droy-Lefaix MT; Braquet P; Buéno L
Life Sci; 1989; 45(6):533-41. PubMed ID: 2570338
[TBL] [Abstract][Full Text] [Related]
16. Platelet activating factor receptor antagonist improves survival and attenuates eicosanoid release in severe endotoxemia.
Fletcher JR; DiSimone AG; Earnest MA
Ann Surg; 1990 Mar; 211(3):312-6. PubMed ID: 2178565
[TBL] [Abstract][Full Text] [Related]
17. Interference of BN 52021, a PAF-acether antagonist, with endotoxin-induced hypotension in the guinea-pig.
Adnot S; Lefort J; Lagente V; Braquet P; Vargaftig BB
Pharmacol Res Commun; 1986 Aug; 18 Suppl():197-200. PubMed ID: 3774845
[No Abstract] [Full Text] [Related]
18. Dexamethasone-induced gastric mucosal damage in the rat: possible role of platelet-activating factor.
Filep JG; Hermán F; Földes-Filep E; Schneider F; Braquet P
Br J Pharmacol; 1992 Apr; 105(4):912-8. PubMed ID: 1324056
[TBL] [Abstract][Full Text] [Related]
19. Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor.
Filep JG; Sirois MG; Rousseau A; Fournier A; Sirois P
Br J Pharmacol; 1991 Dec; 104(4):797-804. PubMed ID: 1667286
[TBL] [Abstract][Full Text] [Related]
20. Platelet-activating factor may mediate dexamethasone-induced gastric damage in the rat.
Filep J; Hermán F; Braquet P
Lipids; 1991 Dec; 26(12):1356-8. PubMed ID: 1819733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
